Calendar

Feb
16
Tue
Gastrointestinal Disorders: Hepatitis
Feb 16 @ 8:00 am – 9:00 am
Mar
1
Tue
Inhibition of CYP450 pathways: Clearance concepts and dose adjustments
Mar 1 @ 8:00 am – 9:00 am
Mar
15
Tue
Neurological Disorders I: Parkinson’s Disease
Mar 15 @ 8:00 am – 9:00 am
Apr
5
Tue
Case discussion: drug-drug interactions in patients with polypharmacy
Apr 5 @ 8:00 am – 9:00 am
Apr
19
Tue
Neurological Disorders II: Dementias
Apr 19 @ 8:00 am – 9:00 am
May
3
Tue
CYP2C19: Relevance of PGx testing for a series of drugs
May 3 @ 8:00 am – 9:00 am
May
17
Tue
Cardiovascular Disorders I: Hypertension and Lipids
May 17 @ 8:00 am – 9:00 am
Jun
7
Tue
Basic cardiac electrophysiological concepts applied to the management of AFib
Jun 7 @ 8:00 am – 9:00 am
Jun
21
Tue
Cardiovascular Disorders II: Congestive Heart Failure
Jun 21 @ 8:00 am – 9:00 am
Jun
22
Wed
Minimizing ADEs & Increasing Safety through Medication Risk Mitigation @ webinar
Jun 22 @ 2:00 pm – 3:00 pm

According to the US Department of Human Services, adverse drug events (ADEs) prolong hospital stays, result in about $3.5 billion of health care costs on a yearly basis, and are the 4th leading cause of death in the United States. Tabula Rasa HealthCare Chief Scientific Officer, Dr. Jacques Turgeon, will discuss the problem of ADEs and their effects for hospital populations; share the science that can help inform solutions for preventing ADEs in all populations; and review the Medication Risk Mitigation™ system developed by TRHC for minimizing ADEs and increasing medication safety.

This webinar is for medical executives, nursing executives, pharmacy executives, quality executives, safety officers, and anyone else involved in avoiding ADEs and preventing unnecessary readmissions.